Healthcare technology diligence
Technology due diligence for healthcare deals: EHR, scheduling and patient access.
Internal systems and sensitive records need authorized access.
Healthcare technology due diligence examines whether a target’s systems support patient access and the acquisition plan. Meo Advisors starts with public scheduling journeys, front-end dependencies and passive infrastructure evidence, then requests authorized access for EHR internals, integrations and operating records. Sensitive information requires agreed handling and appropriate BAA arrangements before review; legal questions go to counsel.
In short
- Start with the patient-facing journey and the systems the acquisition plan depends on.
- Public booking behavior can raise a system question; it cannot establish how the EHR or integration works internally.
- Agree authorized access, data handling and any needed BAA before reviewing sensitive internal evidence.
What is due diligence in healthcare?
Healthcare due diligence reviews the evidence behind a healthcare acquisition, including patient access, technology dependencies and patient-data risk. The technology review asks whether the EHR, scheduling tools and integrations can support the acquisition plan, while keeping public observations separate from internal findings.
Healthcare technology due diligence is the deal-stage review of the systems, integrations and vendor dependencies supporting patient access and the healthcare operating plan.
The healthcare due diligence hub sets out the wider review. The technology due diligence hub covers the shared stack, technical debt and vendor questions across sectors.
What systems limit patient access at a healthcare target?
Scheduling rules, EHR dependencies, routing tools, forms and data integrations can each constrain the patient journey. Public evidence may show a visible failure or inconsistent booking behavior; identifying its cause needs the relevant system records and authorized review.
- Public booking and contact journeys: what a patient can find, reach and complete.
- Scheduling and routing dependencies: which rules and handoffs need internal explanation.
- EHR and integration boundaries: which systems exchange data and which owners can provide evidence.
- Vendor and contract dependencies: which obligations, costs and change limits need documentation.
| Layer | What we check |
|---|---|
| Marketing & Digital Visibility | AI answers and search ranking; Listings and reviews; Paid media; Pricing |
| Technology & Infrastructure | Technical debt; Vendors and SaaS subscriptions; Tags and measurement; Page speed |
| Cybersecurity | External exposure review; Internet-facing endpoints; Certificates and security headers; Penetration testing on request, with authorization |
A visible issue should lead to a scoped question, not an assumption about the whole system. The operational due diligence review connects those system questions with the wider delivery process.
What is visible from outside, and what needs authorized access?
Public pages can show the front end, tags, customer-facing apps, domains and hosting. EHR configuration, integration logic, internal code, patient records and vendor contracts need an agreed evidence request and authorized access; public availability does not authorize active testing.
| Visible from outside | Needs authorized access |
|---|---|
| Front end and templates | App internals |
| Tags and measurement | Data integrations |
| Customer-facing apps | Code and technical debt |
| Domains and hosting | Vendor contracts and SaaS spend |
Before authorization we use passive public sources only: DNS, certificate transparency, third-party internet-scan datasets, and the target’s public pages at normal browsing rates. No port scans, vulnerability scans or login attempts without written authorization.
Do not submit patient information through public forms as part of the outside review. An internal HIPAA risk assessment needs authorized access and runs only within the agreed scope.
What needs a BAA before review?
The need for a BAA depends on the parties’ roles and whether the agreed work involves protected health information. Before any such review, confirm the data required, authorized access, handling arrangements and any needed BAA with the target and counsel.
Keep the review to the evidence needed for the agreed question. Do not treat a BAA as permission for unrestricted system access. Not legal advice; legal questions about HIPAA applicability and agreements go to counsel.
The HIPAA risk assessment scope explains the distinction between public observations and an authorized internal assessment.
How does healthcare technology diligence run?
Start with the acquisition plan and patient-access questions, map the public systems, and request the records needed to resolve internal dependencies. Agree authorization and data handling before access, then turn supported findings into actions with owners and verification steps.
- Agree the healthcare operating priorities and the public journeys in scope.
- Record public observations, their sources and what they cannot establish.
- Request system maps, integration documentation, vendor contracts and other records needed for open questions.
- Confirm authorization and any needed BAA before reviewing sensitive internal evidence.
- Rank supported findings and list unresolved questions separately, with the evidence needed to resolve each.
Use the IT due diligence checklist to structure the technology evidence requests.
What does healthcare technology diligence deliver?
The review delivers a stack map, technical debt flags and an access request list, with patient-access dependencies made explicit. Each finding states its evidence and limits; each unresolved question names the record or authorized check needed to answer it.
See the sample diligence deliverables for the readout format. A company preparing for an exit can use sell-side readiness to organize those records and remediation actions before a buyer’s review.
Meo Advisors Editorial writes and maintains this page. Its numbers are Meo Advisors’ own statements or cited external benchmarks, and every mock is labelled Illustrative. See the editorial policy and corrections process.